Buy Outlook Therapeutics Inc Stock | OTLK Stock Price & Latest News | Public
OTLK

Outlook Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap

    About OTLK

    Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.12
    -0.24
    -0.36
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.09

    Actual EPS
    Q3 2020

    Stats

    Market Cap$156,43M
    Volume24,36k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.74
    1 Year Low$0.50
    Open$1.27
    High$1.28
    Low$1.23

    Buy any stock with any amount of money.

    Download the App
    Download the app